Improved outcomes in nephrotic syndrome. Export

@article{citeulike:6083839, abstract = {Nephrotic syndrome can now be treated effectively in most cases. All patients should be treated with a low-salt diet, diuretics to reduce edema, and statins to normalize serum lipid concentrations. Patients with nephrotic syndrome are prone to deep vein thrombophlebitis, renal vein thrombosis, and pulmonary emboli. Depending on the condition, additional treatment may include corticosteroids, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), cyclosporine, cytotoxic agents, or mycophenolate.}, author = {Appel, Gerald B.}, citeulike-article-id = {6083839}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/16478040}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=16478040}, issn = {0891-1150}, journal = {Cleveland Clinic journal of medicine}, keywords = {ns}, month = {February}, number = {2}, pages = {161--167}, posted-at = {2009-11-08 09:51:34}, priority = {2}, title = {Improved outcomes in nephrotic syndrome.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/16478040}, volume = {73}, year = {2006} }

TY - JOUR ID - citeulike:6083839 L3 - citeulike-article-id:6083839 N2 - Nephrotic syndrome can now be treated effectively in most cases. All patients should be treated with a low-salt diet, diuretics to reduce edema, and statins to normalize serum lipid concentrations. Patients with nephrotic syndrome are prone to deep vein thrombophlebitis, renal vein thrombosis, and pulmonary emboli. Depending on the condition, additional treatment may include corticosteroids, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), cyclosporine, cytotoxic agents, or mycophenolate. IS - 2 JF - Cleveland Clinic journal of medicine SN - 0891-1150 EP - 167 TI - Improved outcomes in nephrotic syndrome. VL - 73 SP - 161 KW - ns AU - Appel, Gerald PY - 2006/02// UR - http://view.ncbi.nlm.nih.gov/pubmed/16478040 ER -